Mehta Sonia D, Leavitt Wendy L, Alex Gijo, Saynhalath Rita, Kiss Edgar
Division of Pediatric Anesthesiology, Department of Anesthesiology, University of Florida College of Medicine, Gainesville, Florida, United States.
Division of Pediatric Anesthesiology, Department of Anesthesiology, UT Southwestern Medical Center, Dallas, Texas, United States.
J Pediatr Genet. 2021 Mar;10(1):53-56. doi: 10.1055/s-0040-1702153. Epub 2020 Feb 17.
Children with mitochondrial disorders represent a subset of patients who require unique anesthetic considerations. Routinely administered medications for general anesthesia, such as propofol, have been shown to increase the risk of developing metabolic acidosis. In addition, both depolarizing and nondepolarizing neuromuscular blockers are contraindicated due to the risk of hyperkalemic cardiac arrest and worsening of preexisting muscle weakness, respectively. These limitations pose challenges while choosing appropriate medications for induction of general anesthesia, especially when the risk of aspiration is high. We present a novel case of using inhaled sevoflurane and intravenous alfentanil to facilitate intubation in a 4-year-old girl with a complex 1 mitochondrial disorder suffering from severe gastroparesis and esophageal dysmotility.
患有线粒体疾病的儿童是一类需要特殊麻醉考量的患者群体。常规用于全身麻醉的药物,如丙泊酚,已被证明会增加发生代谢性酸中毒的风险。此外,去极化和非去极化神经肌肉阻滞剂均为禁忌,因为分别存在高钾血症性心脏骤停的风险和使原有肌肉无力恶化的风险。在选择合适的全身麻醉诱导药物时,这些限制带来了挑战,尤其是在误吸风险较高的情况下。我们报告了一例新颖的病例,一名患有复杂线粒体疾病、严重胃轻瘫和食管运动障碍的4岁女孩,使用吸入七氟烷和静脉注射阿芬太尼辅助插管。